UPCOMING SESSIONS in ET
Wed, Apr 15, 2026
3:00 – 5:00 PM UTC
Newly Diagnosed ATTR Patients Onboarding Session Dr. Stacey Goodman Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 15, 2026 · 3:00 – 5:00 PM UTC
Newly Diagnosed ATTR Patients Onboarding Session
Dr. Stacey Goodman
Click To Register
View all sessions

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Source
University of California Health

Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque- like substance that accumulates in different organs in the body and can cause damage to the organ. There are two ways that the TTR protein can fall apart. One way occurs as a person ages, where the normal TTR protein can fall apart and form amyloid that may no longer be sufficiently cleared by the body. This type of ATTR is known as wild-type ATTR (ATTRwt). The other way occurs when a person inherits a defective TTR gene that causes the TTR protein to spontaneously fall apart. This form of the disease is known as variant ATTR (ATTRv) and can be detected in adults by a genetic test of their TTR gene before they age.